nitrofurantoin and norfloxacin

nitrofurantoin has been researched along with norfloxacin in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (12.00)18.2507
2000's8 (32.00)29.6817
2010's13 (52.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Jones, GL; Stickler, DJ1
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Blango, MG; Mulvey, MA1
Gozalbes, R; Pineda-Lucena, A1
Chen, X; Lin, X; Skolnik, S; Wang, J1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
al-Wali, W; Brumfitt, W; Hamilton-Miller, JM; Smith, GW1
Boger, S; Raz, R1
Cranidis, A; Maraki, S; Mavromanolakis, E; Samonis, G; Tselentis, Y1
Buiting, AG; de Neeling, AJ; Goettsch, W; Hendrix, MG; Nagelkerke, N; Petit, PL; Sabbe, LJ; van Griethuysen, AJ; van Pelt, W1
Cahen, P; Honderlick, P1
Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V1
Lobel, B1
De Neeling, AJ; Geerlings, SE; Hoepelman, AI; Meiland, R1
Burström, B; Ericsson, O; Ljung, R; Reimers, A1
Antoniou, T; Garg, AX; Gomes, T; Hellings, C; Juurlink, DN; Mamdani, MM; Weir, MA; Yao, Z1
Bertrand, X; Faller, JP; Hoen, B; Leroy, J; Sekri, D; Slekovec, C; Talon, D; Vernaz-Hegi, N1
Gram, L; Knudsen, GM; Ng, Y1
Gandhi, S; Garg, AX; Jain, AK; Liu, AR; McArthur, E; Moist, L; Singh, N; Sood, MM1
Buetow, SA; Gauld, NJ; Ikram, RB; Thomas, MG; Zeng, IS1
Gregory, WT; Guran, LA; McDonagh, MS; Price, JR1
Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA1

Reviews

4 review(s) available for nitrofurantoin and norfloxacin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.
    International journal of antimicrobial agents, 2003, Volume: 22 Suppl 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections

2003
Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefaclor; Estriol; Female; Humans; Nitrofurantoin; Norfloxacin; Recurrence; Secondary Prevention; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2016
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
    Microbial pathogenesis, 2022, Volume: 172

    Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacterial; Furazolidone; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Norfloxacin; Novobiocin; Rifampin; Vibrio cholerae; Virulence Factors

2022

Trials

3 trial(s) available for nitrofurantoin and norfloxacin

ArticleYear
Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
    The Quarterly journal of medicine, 1991, Volume: 81, Issue:294

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Recurrence; Time Factors; Urinary Tract Infections

1991
Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6

    Topics: Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Recurrence; Urinary Tract Infections

1991
Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:3

    Topics: Adult; Anti-Infective Agents, Urinary; Enterobacteriaceae; Enterococcus; Feces; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Prospective Studies; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

1997

Other Studies

18 other study(ies) available for nitrofurantoin and norfloxacin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Reduced Susceptibility of Proteus mirabilis to triclosan.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization

2008
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
    Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

    Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium

2010
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Netherlands; Nitrofurantoin; Norfloxacin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2000
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Pathologie-biologie, 2000, Volume: 48, Issue:5

    Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurans; Nitrofurantoin; Norfloxacin; Trimethoprim; Urinary Tract Infections

2000
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
    International journal of antimicrobial agents, 2003, Volume: 22 Suppl 2

    Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections

2003
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Complications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2004
Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients.
    BMJ quality & safety, 2011, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Age Distribution; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Utilization; Female; Fluoroquinolones; Guideline Adherence; Healthcare Disparities; Humans; Middle Aged; Multivariate Analysis; Nitrofurantoin; Norfloxacin; Practice Patterns, Physicians'; Quality Indicators, Health Care; Risk Adjustment; Social Class; Sweden; Trimethoprim; Urinary Tract Infections

2011
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    BMJ (Clinical research ed.), 2011, Sep-12, Volume: 343

    Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents, Urinary; Case-Control Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Logistic Models; Male; Mineralocorticoid Receptor Antagonists; Nitrofurantoin; Norfloxacin; Odds Ratio; Ontario; Patient Admission; Risk; Spironolactone; Trimethoprim, Sulfamethoxazole Drug Combination

2011
Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns.
    International journal of clinical pharmacy, 2012, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Attitude of Health Personnel; Drug Prescriptions; Drug Utilization; Education, Medical, Continuing; Female; Fosfomycin; France; General Practitioners; Guideline Adherence; Health Knowledge, Attitudes, Practice; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Practice Guidelines as Topic; Practice Patterns, Physicians'; Program Evaluation; Regression Analysis; Time Factors; Urinary Tract Infections; Young Adult

2012
Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.
    Applied and environmental microbiology, 2013, Volume: 79, Issue:23

    Topics: Anti-Bacterial Agents; Carbohydrate Metabolism; Colony Count, Microbial; Gene Deletion; Listeria monocytogenes; Microbial Viability; Nitrofurantoin; Norfloxacin; Sigma Factor

2013
Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Jun-16, Volume: 187, Issue:9

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Female; Glomerular Filtration Rate; Humans; Nitrofurantoin; Norfloxacin; Renal Insufficiency; Retrospective Studies; Sex Factors; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2015
Treatment of uncomplicated cystitis: analysis of prescribing in New Zealand.
    The New Zealand medical journal, 2016, Jul-01, Volume: 129, Issue:1437

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Cystitis; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Humans; Middle Aged; New Zealand; Nitrofurantoin; Norfloxacin; Pharmacies; Pregnancy; Pregnancy Complications; Surveys and Questionnaires; Trimethoprim; Young Adult

2016